Yeah, I agree with your odds.
Re: label, I think approval for late-stage metastatic prostate cancer is basically a given. But the contention over labelling may be over whether it can be used early-stage, pre-treatment. There is significant impact on revenue between the two possible outcomes, but not disastrous. The broader label would eventually be granted after (presumably) more long-term safety data is provided.
- Forums
- ASX - By Stock
- TLX
- Go time!
Go time!, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.60 |
Change
0.380(1.79%) |
Mkt cap ! $7.219B |
Open | High | Low | Value | Volume |
$21.40 | $21.69 | $21.12 | $12.86M | 601.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 425 | $21.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.61 | 434 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 352 | 21.560 |
2 | 401 | 21.550 |
11 | 622 | 21.540 |
6 | 863 | 21.530 |
6 | 703 | 21.520 |
Price($) | Vol. | No. |
---|---|---|
21.570 | 39 | 1 |
21.580 | 348 | 4 |
21.590 | 913 | 4 |
21.600 | 327 | 2 |
21.610 | 380 | 2 |
Last trade - 13.48pm 14/10/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |